Novel triple-drug FDC superior to dual combination in type 2 diabetes patients poorly controlled with metformin Medha Baranwal2 Jun 2023 11:30 AM ISTIndia: A recent study has shown a triple-drug fixed-dose combination (FDC) of sitagliptin + dapagliflozin + metformin ER to be superior to dual...
Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 6:26 PM ISTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Novartis in tight spot as HC stays grant of patent for Entresto amid generics fight Farhat Nasim13 Jan 2023 11:59 AM ISTNew Delhi: Amid the earlier patent of blockbuster heart failure drug Entresto expiring on January 16, 2023 concerns rise for the Swiss multinational...
Health Bulletin 18/November/2021 Roshni Dhar18 Nov 2021 5:43 PM ISTHere are Top Health stories of the daySupreme Court defers NEET PG Counselling 2021 hearing, Doctors launch Twitter storm demanding expeditionThe...
Glenmark gets CDSCO panel nod to market Remogliflozin, Teneligliptin, Metformin FDC drug Medical Dialogues Team17 Nov 2021 4:59 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial and bioequivalence study waver, the Subject Expert Committee (SEC) of the Central...
NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma Medical Dialogues Team31 Aug 2021 5:55 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the popular antidiabetic Fixed-Dose Combination (FDC)...
Regularization of 31 FDCs declared rational: Drugmakers told to submit application within 6 months Medical Dialogues Team29 Aug 2021 11:15 AM ISTNew Delhi: In order to regularize Fixed Dose Combinations (FDCs) declared rational by the DTAB in respect of 294 FDCs, the Central Drugs Standard...
CDSCO decides on fate of 3 antibiotic FDCs including Cefixime, Cloxacilli Medical Dialogues Team28 Aug 2021 4:00 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has asked all State and Union Territory (UT) drugs controllers to direct all the...
CDSCO extends deadline to submit details of 19 FDC drugs Medical Dialogues Team21 Aug 2021 7:00 PM ISTNew Delhi: Following several requests for an extension of the deadline for submitting information on the rationality, safety, and efficacy of pre-1988...
CDSCO asks stakeholders to submit data on rationality, safety, & efficacy of older FDCs Medical Dialogues Team11 Aug 2021 12:55 PM ISTNew Delhi: In order to assess the status of fixed dose combination drugs licensed prior to 1988, the Directorate General of Health Services, Central...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 6:21 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
